Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Cash from Investing Activities (2019 - 2025)

Historic Cash from Investing Activities for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $8.7 million.

  • Pulmonx's Cash from Investing Activities rose 2903.27% to $8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.6 million, marking a year-over-year increase of 671376.15%. This contributed to the annual value of $17.5 million for FY2024, which is 97075.24% up from last year.
  • Pulmonx's Cash from Investing Activities amounted to $8.7 million in Q3 2025, which was up 2903.27% from $5.5 million recorded in Q2 2025.
  • Over the past 5 years, Pulmonx's Cash from Investing Activities peaked at $16.3 million during Q1 2025, and registered a low of -$29.1 million during Q4 2021.
  • Over the past 5 years, Pulmonx's median Cash from Investing Activities value was -$727000.0 (recorded in 2022), while the average stood at -$237684.2.
  • As far as peak fluctuations go, Pulmonx's Cash from Investing Activities tumbled by 439210.53% in 2021, and later surged by 214318.18% in 2023.
  • Quarter analysis of 5 years shows Pulmonx's Cash from Investing Activities stood at -$29.1 million in 2021, then surged by 97.5% to -$727000.0 in 2022, then crashed by 278.95% to -$2.8 million in 2023, then soared by 610.6% to $14.1 million in 2024, then plummeted by 38.07% to $8.7 million in 2025.
  • Its Cash from Investing Activities stands at $8.7 million for Q3 2025, versus $5.5 million for Q2 2025 and $16.3 million for Q1 2025.